Evidence map›Paper›PMID 35311582›Full record

ArticleMicrobiology spectrum2022

An Extended Reservoir of Class-D Beta-Lactamases in Non-Clinical Bacterial Strains.

Valérian Lupo, Paola Sandra Mercuri, Jean-Marie Frère, Bernard Joris, Moreno Galleni, Denis Baurain, Frédéric Kerff

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Valérian LupoInBioS-PhytoSYSTEMS, Eukaryotic Phylogenomics, University of Liègegrid.4861.b, Liège, Belgium.
Paola Sandra MercuriInBioS, Center for Protein Engineering, University of Liègegrid.4861.b, Liège, Belgium.
Jean-Marie FrèreInBioS, Center for Protein Engineering, University of Liègegrid.4861.b, Liège, Belgium.
Bernard JorisInBioS, Center for Protein Engineering, University of Liègegrid.4861.b, Liège, Belgium.
Moreno GalleniInBioS, Center for Protein Engineering, University of Liègegrid.4861.b, Liège, Belgium.
Denis BaurainInBioS-PhytoSYSTEMS, Eukaryotic Phylogenomics, University of Liègegrid.4861.b, Liège, Belgium.ORCID 0000-0003-2388-6185
Frédéric KerffInBioS, Center for Protein Engineering, University of Liègegrid.4861.b, Liège, Belgium.
University of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial genes coding for antibiotic resistance represent a major issue in the fight against bacterial pathogens. Among those, genes encoding beta-lactamases target penicillin and related compounds such as carbapenems, which are critical for human health. Beta-lactamases are classified into classes A, B, C, and D, based on their amino acid sequence. Class D enzymes are also known as OXA beta-lactamases, due to the ability of the first enzymes described in this class to hydrolyze oxacillin. While hundreds of class D beta-lactamases with different activity profiles have been isolated from clinical strains, their nomenclature remains very uninformative. In this work, we have carried out a comprehensive survey of a reference database of 80,490 genomes and identified 24,916 OXA-domain containing proteins. These were deduplicated and their representative sequences clustered into 45 non-singleton groups derived from a phylogenetic tree of 1,413 OXA-domain sequences, including five clusters that include the C-terminal domain of the BlaR membrane receptors. Interestingly, 801 known class D beta-lactamases fell into only 18 clusters. To probe the unknown diversity of the class, we selected 10 protein sequences in 10 uncharacterized clusters and studied the activity profile of the corresponding enzymes. A beta-lactamase activity could be detected for seven of them. Three enzymes (OXA-1089, OXA-1090 and OXA-1091) were active against oxacillin and two against imipenem. These results indicate that, as already reported, environmental bacteria constitute a large reservoir of resistance genes that can be transferred to clinical strains, whether through plasmid exchange or hitchhiking with the help of transposase genes.

Indexed as

beta-LactamasesCarbapenemsAnti-Bacterial AgentsBacteriaBacterial ProteinsHumansMicrobial Sensitivity TestsOxacillinPhylogenyAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsOxacillinantimicrobial resistancebeta-lactamasecarbapenemaseOXAphylogenetic classificationsequence clustering

Identifiers

PMID35311582
PMCPMC9045261
OpenAlexW4221037386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.